A key value inflection point (KVIP) is a material de-risking event with the potential to drive significant NAV growth, for example by increasing the possibility of a realisation event such as M&A.
SIML's NAV Growth Framework aims to provide shareholders with more clarity on which milestones and what stage of the development cycle we anticipate our companies will be able to access capital and drive significant NAV growth, through M&A and liquidity events, in the current market environment.
At 30 June 2026, 86.4% of the Life Science Portfolio was in commercial, late-stage and clinical-stage companies. Syncona is funded to deliver all its KVIPs, with four expected by the end of CY2026 and a further four before the end of CY2028.
“With a rich set of key value inflection points expected over the next three years, we expect to build and unlock more latent value across this exciting portfolio of companies, focusing first on the return of a minimum of £250 million proceeds to shareholders in a timely manner, whilst also driving significant future value and growth.”
